fda glp-1 warning news november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Drugs: 2025 Pulse Survey

Possible testing includes: A CMP or BMP when vomiting, diarrhea, poor fluid intake, or kidney risk is present Glucose review in people with diabetes A1C testing after enough time has passed to reflect a meaningful glycemic trend Additional tests based on previous abnormalities or new symptoms Stable Long-Term Monitoring A1C monitoring should follow the patient's diabetes status and treatment goals

23 The FDA recommends that patients remain on each dose of certain GLP-1 RA therapies, namely semaglutide, dulaglutide, and tirzepatide, for at least 4 weeks before dose increases

None of this is instruction for human or animal administration

Why the Obesity GLP-1 Market is Growing

PCOS often involves insulin resistance, anovulation, and elevated androgen levels (such as testosterone), all of which interfere with the normal hormonal signals required for ovulation and conception

Nonfatal stroke risk was decreased by 16% and hospitalization for heart failure by 10%